Genvax

?? Meet the finance experts driving investment into animal agriculture at #AnimalAgTech in Dallas on April 8-9: Mikayla (Sullivan) Mooney, Partner at Ag Startup Engine, is a former agtech founder turned investor. After launching KinoSol, a global food dehydration start-up, she transitioned to venture capital, first at ISA Ventures and now leading Ag Startup Engine’s third fund, focusing on early-stage agtech innovation. Aidan Connolly, President at AgriTech Capital, is a seasoned agribusiness investor with over 30 years of experience. He has worked across strategy, operations, and global agribusiness leadership, backing innovations that drive growth and efficiency in food and agriculture. Duane Cantrell, CEO & Managing Partner at Fulcrum Global Capital, invests in biotech and agtech solutions that enhance yield, reduce food waste, and optimize the global agriculture supply chain, with a focus on technologies closer to production. Carter Williams, CEO at iSelect Fund, has invested in more than 70 early-stage ventures, leveraging his expertise in?leading start-ups to successful exits. Spencer Swayze, CFA, Managing Partner at Osiris Growth Capital, specializes in investments across animal productivity, sustainability, and functional ingredients. He previously led growth equity and buyout investments at Paine Schwartz Partners and held key investment roles at UTIMCO. Kyle Welborn, Managing Director at The Yield Lab, is a hands-on agtech investor, serving as board chair at NanoGuard Technologies and a board member at Ascribe Bioscience. Find out more about the program and speakers, download the summit brochure → https://lnkd.in/gMTui3hf

Kudos to the USDA and Secretary Brooke Rollins for their proactive measures against avian influenza! Their recent announcement to invest up to $100 million in projects focusing on prevention, therapeutics, vaccines, and research demonstrates a strong commitment to supporting our poultry industry and safeguarding public health. This initiative is part of a comprehensive strategy, which includes enhancing biosecurity measures and providing financial relief to affected farmers, aiming to curb the spread of the virus and stabilize egg prices. Such decisive actions are essential in mitigating the impact of avian influenza and ensuring the resilience of our agricultural sector. We applaud the USDA for stepping up with this effort! Read here: https://lnkd.in/gCdrdgrF #AnimalHealth #PoultryIndustry #LivestockFarming #AgTech #USDA #PublicHealth #FoodSecurity #AgPolicy #BIRDFLU

https://lnkd.in/gk4p9bBi

Our co-founder and CEO, Joel Harris, was named 2025 Biotech Leader of the Year at the?Iowa Biotechnology Association (IowaBio) Biotech Showcase & Conference! This award?honors exceptional individuals who have shown leadership, consistently delivered innovative biotech solutions, and actively advocate for Iowa's biotechnology sector. Congratulations, Joel! #IBSC

Want to learn more about raising capital and working with strategic investors for biotech startups?? Join Ag Startup Engine’s Mikayla (Sullivan) Mooney and Joel Harris at the Iowa Biotechnology Association (IowaBio) Showcase and Conference on Wednesday, March 5th! Joel will share key insights from building Genvax and navigating the biotech funding landscape. ?? To learn more about the event visit:?https://lnkd.in/ges7Ri8w

?? Genvax Technologies is celebrating 4 years of innovation and progress! ?? From our early vision to where we stand today, it has been an incredible journey. None of this would be possible without our dedicated team, supportive investors, trusted partners, and the broader animal health community that believes in our mission. Over the past four years, we have: ? Built a world-class team dedicated to advancing self-amplifying RNA vaccines. ? Secured key funding to drive our technology forward. ? Pioneered solutions for animal health and future pandemic preparedness. Thank you to everyone who has supported us on this journey! Here's to the future of Genvax and the impact we continue to make. ?? #GenvaxTechnologies #4YearAnniversary #AnimalHealth #BiotechInnovation #ThankYou

#iowanshelpingiowans

?? Major Milestone for Self-Amplifying mRNA in Human Health ?? The European Commission just approved the first self-amplifying RNA (saRNA) vaccine for humans, marking a significant leap forward in vaccine technology. This decision, based on EMA’s recommendation, validates the power of saRNA and lipid nanoparticle (LNP) delivery systems—a field that continues to evolve at an incredible pace. At Genvax Technologies, we’ve been pioneering the use of saRNA + LNP for animal health, where speed, adaptability, and cost-efficiency are game-changers for protecting livestock and ensuring food security. This approval underscores the broader potential of the platform and reinforces the importance of regulatory pathways for next-gen RNA vaccines. As we push forward in animal health, we’re excited to see how these innovations will continue shaping both human and veterinary medicine. Congrats to CSL and Arcturus Therapeutics on this milestone! https://lnkd.in/dqinSB7F #SelfAmplifyingRNA #saRNA #mRNA #VaccineInnovation #AnimalHealth #HumanHealth #Biotech #GenvaxTechnologies

?? ????????'?? ?????? ???????? ?????????????????????? ???? ?????? ???????????????????? ???????????? ????????????????? ?? Closing off our production animal track for the afternoon, Aaron Schacht, CEO, BiomEdit moderated a discussion exploring of the current product landscape, with a focus on the most exciting new innovations, from diagnostics to mRNA technology, and discuss how they are poised to evolve over the next decade. Thank you to panelists Eve Hanks (MI:RNA Diagnostics), Adrian Grosu (Stonehaven Cozmix Group (SC Group) , Lucas Huntimer (Genvax) and Colin South (ArkeaBio?) for an exciting conversation. #AHNTI #AnimalHealth #10YearsOfAHNTI

What has led to disruptive innovation in livestock #animalhealth in the last 10 years? Vaccines! #AHNTI #10YearsOfAHNTI